Tag: Disease

Markets

Eli Lilly : Kisunla Approved In EU For Early Symptomatic Alzheimer’s Disease

26/09/2025
mhsj

(RTTNews) – Eli Lilly and Co. (LLY) announced that the European Commission has approved marketing authorization…

Investment Strategies

Alzheimer’s Disease: When All Else Fails

20/08/2025
mhsj

This article was written by Follow Retired history instructor. Alzheimer’s disease researcher for the past two…

Investment Strategies

aTyr Pharma: Estimating Their Phase 3 Lung Disease Trial Outcome (NASDAQ:ATYR)

19/08/2025
mhsj

This article was written by Follow CC Abbott (on Stocktwits)Both my spouse and I have a…

Investment Strategies

Judge Allows Testimony That Abbott, Mead Johnson Baby Formula Caused Disease

05/05/2025
mhsj

A federal judge on said she will allow expert testimony that formula made by Abbott Laboratories…